Contact this trialFirst, we need to learn more about you.
NMDA Receptor Antagonist
Nebulized Ketamine for Depression
Recruiting2 awardsPhase 3
Brooklyn, New York
This trial is testing nebulized ketamine to see if it can help reduce depressive symptoms in people with moderate to severe depression. It is a controlled study where neither the participants nor the researchers know who
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service